Geode Capital Management’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-330,898
Closed -$46.3M 4194
2018
Q4
$46.3M Buy
330,898
+15,413
+5% +$2.34M 0.01% 770
2018
Q3
$53.9M Buy
315,485
+65,844
+26% +$11.1M 0.02% 765
2018
Q2
$43.3M Buy
249,641
+35,529
+17% +$5.34M 0.01% 845
2018
Q1
$24.7M Buy
214,112
+9,030
+4% +$960K 0.01% 1110
2017
Q4
$17.3M Sell
205,082
-12,144
-6% -$1.01M 0.01% 1364
2017
Q3
$20M Buy
217,226
+37,372
+21% +$2.9M 0.01% 1237
2017
Q2
$14.4M Buy
179,854
+43,578
+32% +$2.41M 0.01% 1436
2017
Q1
$5.73M Buy
136,276
+44,193
+48% +$1.82M ﹤0.01% 2009
2016
Q4
$2.96M Sell
92,083
-8,697
-9% -$223K ﹤0.01% 2404
2016
Q3
$2.64M Buy
100,780
+3,487
+4% +$91.2K ﹤0.01% 2389
2016
Q2
$2.25M Buy
97,293
+40,225
+70% +$1M ﹤0.01% 2401
2016
Q1
$1.56K Buy
57,068
+2,126
+4% +$44.5K ﹤0.01% 2609
2015
Q4
$1.56M Buy
54,942
+10,700
+24% +$287K ﹤0.01% 2627
2015
Q3
$773K Buy
44,242
+10,582
+31% +$207K ﹤0.01% 3022
2015
Q2
$606K Buy
33,660
+4,868
+17% +$66.5K ﹤0.01% 3122
2015
Q1
$358K Buy
28,792
+997
+4% +$12.4K ﹤0.01% 3334
2014
Q4
$326K Buy
+27,795
New +$324K ﹤0.01% 3381

Other funds holding LOXO

Geode Capital Management's LOXO Position: Q1 2019 in Review

Geode Capital Management sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 330,898 shares — an estimated $46.3M sold.

Geode Capital Management first reported a position in LOXO in Q4 2014 and held it in 17 quarters. The position peaked at $53.9M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Geode Capital Management reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Geode Capital Management sold 330,898 Loxo Oncology, Inc shares in Q1 2019, an estimated $46.3M.
  • Geode Capital Management first reported a position in Loxo Oncology, Inc in Q4 2014 and held it in 17 quarters.
  • Geode Capital Management's Loxo Oncology, Inc position peaked at $53.9M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Geode Capital Management's 13F filing for Q1 2019, filed 14 May 2019.